Mark Altmeyer

Mr. Mark F.
Altmeyer is a Chairman at Calluna Pharma, Inc., an Independent Director at Alector, Inc., a Chairman-Supervisory Board at AM-Pharma BV and a Chief Executive Officer & Director at Arvelle Therapeutics International GmbH.
He is on the Board of Directors at Aculys Pharma LLC, Alector, Inc., Novaremed AG, Arvelle Therapeutics International GmbH and Contact of Mercer County.
Mr. Altmeyer was previously employed as an Independent Director by Clarion Healthcare LLC, a Chief Executive Officer & Executive Director by Arvelle Therapeutics BV, a President & Chief Commercial Officer by Axovant Sciences GmbH, an Independent Director by Myovant Sciences Ltd., a President & Chief Commercial Officer by Axovant Sciences, Inc., a President & Chief Commercial Officer by Axovant Gene Therapies Ltd., a President & Chief Executive Officer by Otsuka America Pharmaceutical, Inc., and a Senior Vice President by Bristol Myers Squibb Co. He also served on the board at Roivant Sciences GmbH.
He received his undergraduate degree from Middlebury College and an MBA from Harvard Business School.